Females could cut their likelihood of funding heart disease treatments through expat health insurance policies by taking an aspirin every day.
However, a peer-reviewed article in the Journal of Women's Health found fewer than half of the ladies who could benefit from taking this drug – particularly those deemed to have an elevated risk of suffering from cardiovascular conditions – consume the medicine daily.
Over 200,000 females took part in an online survey that assessed their likelihood of developing heart diseases, but only between 41 and 48 per cent of those who should take an aspirin every 24 hours reported that they did so.
Participants were more likely to take the tablet if they had high cholesterol levels or a family history of cardiovascular ailments, the investigation revealed.
Caucasian respondents also had a better chance of taking aspirin in order to prevent the development of heart disease than those from other ethnic or racial groups, which echoes other studies that have shown similar demographic trends.
Improved educational programmes could increase awareness of this treatment and could prevent a substantial number of women from suffering from cardiac problems, the authors of the article – titled Underuse of Aspirin for Primary and Secondary Prevention of Cardiovascular Disease Events in Women and led by Mosca Jones- concluded.
"Based on this survey, it is evident that the majority of women for whom aspirin is recommended for prevention of cardiovascular disease are not following national guidelines," editor-in-chief of the journal and executive director of the Virginia Commonwealth University Institute for Women's Health Susan Kornstein said.
Heart disease is the most common cause of female deaths in the United States, although only 54 per cent of women knew this fact, previous research – entitled Twelve-year follow-up of American women's awareness of cardiovascular disease risk and barriers to heart health and published in Circulation: Cardiovascular Quality and Outcomes – revealed.